• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

介绍新的 BTS 指南:非结核分枝杆菌肺部疾病(NTM-PD)的管理。

Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).

机构信息

Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, UK.

Department of Medicine, University of Cambridge, Cambridge, UK.

出版信息

Thorax. 2017 Nov;72(11):969-970. doi: 10.1136/thoraxjnl-2017-210929.

DOI:10.1136/thoraxjnl-2017-210929
PMID:29054887
Abstract

The new BTS Guidelines for the management of non-tuberculous mycobacterial pulmonary disease combine the best available evidence with expert consensus to generate a set of pragmatic Guidelines, published as a supplement to this issue of Thorax, to assist in the management of these challenging infections.

摘要

新的 BTS 非结核分枝杆菌肺病管理指南结合了最佳现有证据和专家共识,生成了一套实用的指南,作为本期《胸》杂志的增刊发表,以协助管理这些具有挑战性的感染。

相似文献

1
Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).介绍新的 BTS 指南:非结核分枝杆菌肺部疾病(NTM-PD)的管理。
Thorax. 2017 Nov;72(11):969-970. doi: 10.1136/thoraxjnl-2017-210929.
2
Management of nontuberculous mycobacterial (NTM) lung disease.非结核分枝杆菌(NTM)肺病的管理。
Semin Respir Crit Care Med. 2013 Feb;34(1):135-42. doi: 10.1055/s-0033-1333575. Epub 2013 Mar 4.
3
Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects.非结核分枝杆菌肺病:患者、原则与展望。
Clin Infect Dis. 2024 Oct 15;79(4):e27-e47. doi: 10.1093/cid/ciae421.
4
Advances in diagnosis and treatment of non-tuberculous mycobacterial lung disease.非结核分枝杆菌肺病的诊断与治疗进展。
Diagn Microbiol Infect Dis. 2024 Jun;109(2):116254. doi: 10.1016/j.diagmicrobio.2024.116254. Epub 2024 Mar 12.
5
Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.影响HIV阴性患者非结核分枝杆菌肺部感染治疗起始的因素;一项多中心观察性研究。
Respir Med. 2016 Nov;120:101-108. doi: 10.1016/j.rmed.2016.10.001. Epub 2016 Oct 6.
6
Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.非结核分枝杆菌肺病的医学管理
Thorac Surg Clin. 2019 Feb;29(1):65-76. doi: 10.1016/j.thorsurg.2018.09.001.
7
Antibiotic treatment for nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病的抗生素治疗
Expert Rev Respir Med. 2016;10(5):557-68. doi: 10.1586/17476348.2016.1165611. Epub 2016 Mar 30.
8
Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.非结核分枝杆菌肺病一年改善情况的预测因素:一项为期11年的回顾性多中心研究。
PLoS Negl Trop Dis. 2017 Aug 7;11(8):e0005841. doi: 10.1371/journal.pntd.0005841. eCollection 2017 Aug.
9
Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病的微生物学诊断。
Clin Chest Med. 2015 Mar;36(1):43-54. doi: 10.1016/j.ccm.2014.11.005. Epub 2014 Dec 18.
10
Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.非结核分枝杆菌性肺病中抗生素耐药的管理:挑战与新方法。
Expert Rev Respir Med. 2019 Sep;13(9):851-861. doi: 10.1080/17476348.2019.1638765. Epub 2019 Jul 8.

引用本文的文献

1
Supporting Patients with Nontuberculous Mycobacterial Pulmonary Disease: Ensuring Best Practice in UK Healthcare Settings.支持非结核分枝杆菌肺病患者:确保英国医疗环境中的最佳实践。
Pharmacy (Basel). 2024 Aug 21;12(4):126. doi: 10.3390/pharmacy12040126.
2
Development of a rapid detection method for the macrolide resistance gene in using the amplification refractory mutation system-loop-mediated isothermal amplification method.应用扩增受阻突变系统-环介导等温扩增法快速检测 中的大环内酯类耐药基因。
Microbiol Spectr. 2024 Apr 2;12(4):e0233923. doi: 10.1128/spectrum.02339-23. Epub 2024 Feb 16.
3
A Comparison of Clinical and Radiographic Signs of Nontuberculous Mycobacterial Pulmonary Disease, Destructive Drug-Resistant Pulmonary Tuberculosis and a Combination of Nontuberculous Mycobacterium Pulmonary Disease and Pulmonary Tuberculosis.
非结核分枝杆菌肺病、破坏性耐多药肺结核以及非结核分枝杆菌肺病与肺结核合并症的临床及影像学特征比较
Pathogens. 2023 Jun 29;12(7):887. doi: 10.3390/pathogens12070887.
4
Factors Associated with Treatment Outcome in Patients with Nontuberculous Mycobacterial Pulmonary Disease: A Large Population-Based Retrospective Cohort Study in Shanghai.非结核分枝杆菌肺病患者治疗结果的相关因素:上海一项基于大人群的回顾性队列研究
Trop Med Infect Dis. 2022 Feb 15;7(2):27. doi: 10.3390/tropicalmed7020027.
5
Apramycin Overcomes the Inherent Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus.Apramycin 克服了脓肿分枝杆菌固有的抗菌杀菌活性缺乏。
Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0151021. doi: 10.1128/AAC.01510-21. Epub 2021 Dec 20.
6
Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey.中国的非结核分枝杆菌:一项全国性调查的发病率和抗菌药物耐药谱。
Infect Dis Poverty. 2021 Apr 29;10(1):59. doi: 10.1186/s40249-021-00844-1.
7
Nontuberculous mycobacteria: A report of eighteen cases from a tertiary care center in India.非结核分枝杆菌:来自印度一家三级护理中心的18例报告。
Lung India. 2020 Nov-Dec;37(6):495-500. doi: 10.4103/lungindia.lungindia_365_19.
8
A case of pleural effusion caused by Mycobacterium fortuitum and Mycobacterium mageritense coinfection.一例由偶然分枝杆菌和脓肿分枝杆菌合并感染引起的胸腔积液。
BMC Infect Dis. 2019 Aug 15;19(1):720. doi: 10.1186/s12879-019-4366-8.
9
Simple Identification of Mycobacterial Species by Sequence-Specific Multiple Polymerase Chain Reactions.通过序列特异性多重聚合酶链反应简单鉴定分枝杆菌菌种
Curr Microbiol. 2019 Jul;76(7):791-798. doi: 10.1007/s00284-019-01661-4. Epub 2019 May 9.
10
Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens: seven year experience in a UK hospital.从呼吸道标本中分离出的非结核分枝杆菌的临床相关性:英国一家医院的七年经验。
Sci Rep. 2019 Feb 11;9(1):1730. doi: 10.1038/s41598-018-37350-8.